EK1C4

Description:

EK1C4 is one of a series of lipopeptides derived from EK1 , EK1C4 was the most potent fusion inhibitor against SARS-CoV-2 S protein-mediated membrane fusion and pseudovirus infection.

Sequence:

SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-GSGSG-PEG4-Chol
  • General
  • References
  • Comments (0)
  • Name EK1C4
    Category COVID-19
    One Letter Code SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-GSGSG-PEG4-Chol
    Three Letter Code { Ser }{ Leu }{ Asp }{ Gln }{ Ile }{ Asn }{ Val }{ Thr }{ Phe }{ Leu }{ Asp }{ Leu }{ Glu }{ Tyr }{ Glu }{ Met }{ Lys }{ Lys }{ Leu }{ Glu }{ Glu }{ Ala }{ Ile }{ Lys }{ Lys }{ Leu }{ Glu }{ Glu }{ Ser }{ Tyr }{ Ile }{ Asp }{ Leu }{ Lys }{ Glu }{ Leu }-{ Gly }{ Ser }{ Gly }{ Ser }{ Gly }-PEG4-Chol
    Molecular Weight 4677.260
    Application COVID-19
    Shuai Xia, Meiqin Liu et al. "Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion". Cell Research volume 30, 343–355 (2020).
    #[first_name]
    #[create_date]
    #[comment]
    Reply(#[reply_num])
    #[like_num]
  • #[first_name]
    #[create_date]
    #[comment]
    Reply
    #[like_num]